Lloyd A. Rowland, General Counsel of CytomX Therapeutics CTMX, has filed 0 purchases and 6 sales on the open market. The latest trade was on 25/03/18.

LR

LR

Lloyd A. Rowland

General Counsel

Company

CytomX Therapeutics CTMX

First filing

23/02/06

Trades

17 trades

Buys / sales

0 / 6

12-month net buying

No record

Last trade

25/03/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CytomX TherapeuticsCTMX	Open-market sale	25/03/18	25/03/20	10,203 sh	$0.60	$6,121.8	−7.8%
CytomX TherapeuticsCTMX	Open-market sale	24/08/20	24/08/22	4,181 sh	$1.23	$5,142.63	−3.1%
CytomX TherapeuticsCTMX	Open-market sale	24/03/19	24/03/21	5,268 sh	$2.09	$11,010.12	−4.3%
CytomX TherapeuticsCTMX	Open-market sale	23/12/20	23/12/22	4,077 sh	$1.38	$5,626.26	−4.0%
CytomX TherapeuticsCTMX	Open-market sale	23/09/22	23/09/22	5,486 sh	$1.30	$7,131.8	−6.4%
CytomX TherapeuticsCTMX	Open-market sale	23/03/16	23/03/20	2,037 sh	$1.98	$4,033.26	−2.8%